Skip to content
Logo GenoSplice
  •  
  •  
  •  
  • Communication
    • News & Events
    • Scientific Literature
    • Customers
  • Company
    • Company profile
    • Team
    • Career Oportunities
    • Contact
  • Way To Work
    • Overview
    • Partnering
    • Partners
  • Sequencing
  • Alt. Splicing
  • Services
    • Overview
    • RNA Analysis
    • DNA Analysis
    • Epigenetics
    • Data Integration
    • Wet Lab
    • More…
  • Home
GenoSplice provides Bioinformatics as a Service (BaaS) for sequencing and microarray, with expertise in splicing
Result_Driven.jpg user-friendly.jpg tailored_solution.jpg excellence.jpg

  • Latest News

    • Nucleic Acids Res: Alternative splicing of CNOT7 diversifies CCR4-NOT functions June 8, 2017
    • In Cell Discovery: Translation in astrocyte distal processes sets molecular heterogeneity at the gliovascular interface April 21, 2017
    • GenoSplice is proud to announce its recent publication in Developmental Cell: An Orchestrated Intron Retention Program in Meiosis Controls Timely Usage of Transcripts during Germ Cell Differentiation April 4, 2017
    • In Int J Obes (Lond).: “Pharmacological modulation of LMNA SRSF1-dependent splicing abrogates diet-induced obesity in mice.” March 14, 2017
    • In Proc Natl Acad Sci U S A.: “Novel combinatorial screening identifies neurotrophic factors for selective classes of motor neurons.” March 14, 2017
    • J Hepatol.: “Type I interferon signaling in systemic immune cells from patients with alcoholic cirrhosis and its association with outcome.” January 4, 2017
    • Med Sci (Paris).: “Deregulation of pre-messenger RNA splicing and rare diseases.” January 4, 2017

  • Follow GenoSplice

    Stay connected with GenoSplice!
    GenoSplice on LinkedIn
    GenoSplice on Twitter
    GenoSplice on Facebook

  • Leader in Bioinformatics

    Try EASANA®!
    Our data visualization interface

    Try FAST DB®!
    Our alternative splicing database

Copyright ®2012 GenoSplice technology SARL, Company n°509 186 276, All Rights reserved. Legal notice | Contact